NCT04022733View on ClinicalTrials.gov

Remifentanil in Deep vs Moderate Neuromuscular Blocks During Surgical Pleth Index-guided Anesthesia for Laparoscopic Herniorrhaphy

NACompletedINTERVENTIONAL

Enrollment

134

Participants

Timeline

Start Date

October 30, 2019

Primary Completion Date

August 3, 2021

Study Completion Date

August 3, 2021

Conditions

Hernia Abdominal Wall

Interventions

DRUG

Moderate neuromuscular block

maintaining of moderate neuromuscular block (train-of-four count 1-2) during surgery, reversal using neostigmine 50 ug/kg and glycopyrrolate 10 ug/kg

DRUG

Deep neuromuscular block

maintaining of deep neuromuscular block (posttetanic count 1-2) during surgery, reversal using sugammadex 4 mg/kg based on actual body weight

Trial Locations (1)

Unknown

Department of Anesthesiology and Pain Medicine, Ajou University School of Medicine, Suwon

All Listed Sponsors

lead

Ajou University School of Medicine

OTHER

NCT04022733 - Remifentanil in Deep vs Moderate Neuromuscular Blocks During Surgical Pleth Index-guided Anesthesia for Laparoscopic Herniorrhaphy | Biotech Hunter | Biotech Hunter